Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|October 16, 2012
Proximity of first sexual intercourse to menarche and risk of high-grade cervical diseaseÁngela María Ruiz, Jaime Enrique Ruiz, Andrés Velásquez Gavilanes, et al.
International Journal of Cancer|November 7, 2025
Controlled trial of cervical cancer screening frequency among human-papillomavirus-vaccinated womenMònica Ortega Llobet, Penelope Gray, Iacopo Baussano, et al.
Human Vaccines & Immunotherapeutics|November 15, 2016
Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12-15 years: Interim analysis of a large community-randomized controlled trialMatti Lehtinen, Tiina Eriksson, Dan Apter, et al.
Vaccine|January 17, 2015
Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trialMatti Lehtinen, Dan Apter, Iacopo Baussano, et al.
NPJ Vaccines|August 13, 2024
Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort studyPenelope Gray, Filipe Colaço Mariz, Carina Eklund, et al.
The Journal of Infectious Diseases|March 13, 2020
Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is AppliedSimopekka Vänskä, Tapio Luostarinen, Iacopo Baussano, et al.
Cancer Medicine|September 28, 2021
Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in FinlandMatti Lehtinen, Dan Apter, Tiina Eriksson, et al.
The Lancet. Infectious Diseases|June 3, 2021
Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trialsFilipe Colaço Mariz, Penelope Gray, Noemi Bender, et al.
NPJ Vaccines|March 5, 2020
Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccinesFilipe Colaço Mariz, Noemi Bender, Devasena Anantharaman, et al.
International Journal of Cancer|January 30, 2018
Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II)Penelope Gray, Johanna Palmroth, Tapio Luostarinen, et al.
Pageof 5